January 31, 2024 01:45 PM EST
Health Tech

In­sur­ers warn about ris­ing med­ical costs, dis­ap­point­ing in­vestors as a lu­cra­tive mar­ket starts to shift

Ngai Yeung

Health Tech Reporter

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Some of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

GSK ter­mi­nates Phase 2 tri­al of HBV ther­a­peu­tic vac­cine

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

A service from the Financial Times